some fascinating bits in here.
so that puts to bed entirely the "Teva walked because it wasn't a priority, Teva and MSB mutually agreed to separate" nonsense: Teva exercised a contractual right under the DCA. As we know, the trial had recruited well, so that right kicks in IF AND ONLY IF the surrogate endpoints weren't met. Funny that Silviu didn't answer that question when directly asked on the conference call all that time ago?
Could he have been more candid?
It also seems to be a pattern that if Silviu gets a question he doesn't like, he answers a different question. On the Q1 conference call, this was also evident:
it really, really wasn't Silviu. Is that because the interim hasn't been 'brought forward at all?
Ann: First Quarter Results On Form 6K, page-2
-
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211966 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 136540 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |